Yevgeny Valenrod

Array ( [id] => 12766021 [patent_doc_number] => 20180147175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-31 [patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF MOVEMENT DISORDERS [patent_app_type] => utility [patent_app_number] => 15/878373 [patent_app_country] => US [patent_app_date] => 2018-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6693 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15878373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15451065 [patent_doc_number] => 20200038356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-06 [patent_title] => SPECIALIZED PRO-RESOLVING LIPID MEDIATORS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES AND/OR AUTOIMMUNE DISEASES [patent_app_type] => utility [patent_app_number] => 16/478740 [patent_app_country] => US [patent_app_date] => 2018-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4726 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16478740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15132695 [patent_doc_number] => 10479794 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-19 [patent_title] => Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide [patent_app_type] => utility [patent_app_number] => 15/865695 [patent_app_country] => US [patent_app_date] => 2018-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23018 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 299 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15865695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14119145 [patent_doc_number] => 10246417 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-02 [patent_title] => Picolinamides as fungicides [patent_app_type] => utility [patent_app_number] => 15/862769 [patent_app_country] => US [patent_app_date] => 2018-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67879 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 244 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15862769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15975557 [patent_doc_number] => 10668080 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-02 [patent_title] => Phosphaplatin compounds as therapeutic agents for treatment of bone or blood cancers [patent_app_type] => utility [patent_app_number] => 16/475170 [patent_app_country] => US [patent_app_date] => 2018-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 5337 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16475170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17844838 [patent_doc_number] => 11434190 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-06 [patent_title] => Inhibitors of SOX18 protein activity for treating angiogenesis-and/or lymphangiogenesis-related diseases [patent_app_type] => utility [patent_app_number] => 16/472882 [patent_app_country] => US [patent_app_date] => 2017-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 24 [patent_no_of_words] => 30105 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16472882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13311241 [patent_doc_number] => 20180207157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-26 [patent_title] => (4-((3R,4R)-3-METHOXYTETRAHYDRO-PYRAN-4-YLAMINO)PIPERIDIN-1-YL)(5-METHYL-6-(((2R,6S)-6-(P-TOLYL)TETRAHYDRO-2H-PYRAN-2-YL)METHYLAMINO)PYRIMIDIN-4-YL)METHANONE CITRATE [patent_app_type] => utility [patent_app_number] => 15/849929 [patent_app_country] => US [patent_app_date] => 2017-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11440 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15849929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13167851 [patent_doc_number] => 10100029 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-16 [patent_title] => Combretastatin analogs [patent_app_type] => utility [patent_app_number] => 15/849150 [patent_app_country] => US [patent_app_date] => 2017-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 19 [patent_no_of_words] => 11968 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 222 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15849150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12637188 [patent_doc_number] => 20180104226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-19 [patent_title] => ANTI-MALARIAL AGENT [patent_app_type] => utility [patent_app_number] => 15/847432 [patent_app_country] => US [patent_app_date] => 2017-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6520 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15847432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15586221 [patent_doc_number] => 20200069645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-05 [patent_title] => Use Of Carbamate Compound For Prevention, Alleviation Or Treatment Of Pruritus [patent_app_type] => utility [patent_app_number] => 16/468788 [patent_app_country] => US [patent_app_date] => 2017-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4155 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16468788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14435309 [patent_doc_number] => 20190175526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-13 [patent_title] => METHODS FOR TREATING CANCER [patent_app_type] => utility [patent_app_number] => 15/839883 [patent_app_country] => US [patent_app_date] => 2017-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2891 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15839883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12364068 [patent_doc_number] => 09956215 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2018-05-01 [patent_title] => Methods of treating cancer with farnesyltransferase inhibitors [patent_app_type] => utility [patent_app_number] => 15/820157 [patent_app_country] => US [patent_app_date] => 2017-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 40937 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15820157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12675430 [patent_doc_number] => 20180116976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-03 [patent_title] => METHODS AND COMPOSITIONS FOR UNWANTED OR ABNORMAL MUSCLE CONTRACTIONS [patent_app_type] => utility [patent_app_number] => 15/819881 [patent_app_country] => US [patent_app_date] => 2017-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39449 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15819881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16908037 [patent_doc_number] => 11040054 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-22 [patent_title] => Estrogen sensing through GPER1 regulates normal and malignant liver growth [patent_app_type] => utility [patent_app_number] => 16/349715 [patent_app_country] => US [patent_app_date] => 2017-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 64 [patent_figures_cnt] => 82 [patent_no_of_words] => 21561 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16349715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15144967 [patent_doc_number] => 20190350961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-21 [patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF ABERRANT ANGIOGENESIS [patent_app_type] => utility [patent_app_number] => 16/348860 [patent_app_country] => US [patent_app_date] => 2017-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45993 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -40 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16141255 [patent_doc_number] => 10703688 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-07 [patent_title] => Method for producing organic acids and organic acid degradation compounds from biomass [patent_app_type] => utility [patent_app_number] => 15/810125 [patent_app_country] => US [patent_app_date] => 2017-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 3909 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15810125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13354551 [patent_doc_number] => 20180228815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-16 [patent_title] => NARINGENIN AND ASIATIC ACID COMBINATION TREATMENT OF CANCERS [patent_app_type] => utility [patent_app_number] => 15/808344 [patent_app_country] => US [patent_app_date] => 2017-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11320 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15808344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12231950 [patent_doc_number] => 20180064813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-08 [patent_title] => 'Oral Composition for Delivery of Drugs and Other Substances' [patent_app_type] => utility [patent_app_number] => 15/807389 [patent_app_country] => US [patent_app_date] => 2017-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9589 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15807389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15975613 [patent_doc_number] => 10668108 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-02 [patent_title] => Compositions and methods of treating liver disease [patent_app_type] => utility [patent_app_number] => 16/343157 [patent_app_country] => US [patent_app_date] => 2017-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 6957 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16343157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14990817 [patent_doc_number] => 20190314366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => VILAZODONE INCLUSION COMPLEXES, COMPOSITIONS AND PREPARATION THEREOF [patent_app_type] => utility [patent_app_number] => 16/343171 [patent_app_country] => US [patent_app_date] => 2017-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9408 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16343171 [rel_patent_id] =>[rel_patent_doc_number] =>)